.png)
Agenzia Italiana del Farmaco
home
Highlights
-
15 Apr 2025
Press releases
AIFA-Regions working group: shared calculation method for the class economic impact of glyphozines
This was a fruitful meeting, as it was decided to share the calculation method to assess the economic impact of the class change for this category of drugs.
-
11 Apr 2025
Press releases
AIFA Board approves the call for independent research on rare diseases for 2025
The call is addressed to all Italian researchers in organisations and institutions wishing to conduct non-commercial studies.
-
11 Apr 2025
Press releases
AIFA Board of Directors approves the reimbursability of 2 medicines
At its extraordinary meeting on 10 April 2025, the Board of Directors of the Italian Medicines Agency decided that an orphan medicine and a new chemical molecule should be eligible for reimbursement by the National Health Service (NHS).
-
17 Apr 2025
Publications
"Horizon Scanning: scenario dei medicinali in arrivo”. AIFA pubblica il Rapporto 2025
Il Rapporto Horizon Scanning ha lo scopo di fornire informazioni sui nuovi medicinali e sulle nuove indicazioni che hanno ricevuto un parere positivo dell’Agenzia Europea per i Medicinali (EMA) nel 2024 o che potrebbero riceverlo nell’anno in corso.
News
18 Apr 2025
Consumption and pharmaceutical expenditure
Procedura di revisione e validazione degli elenchi delle indicazioni terapeutiche per fProcedure for the review and validation of lists of therapeutic indications for innovative medicines by pharmaceutical companiesarmaci innovativi da parte delle Aziende farmaceutiche
14 Apr 2025
Transparency Lists
AIFA updates the Transparency Lists
07 Apr 2025
Monitoring pharmaceutical expenditure
Biosimilar medicines in Italy: AIFA reports updated
07 Apr 2025
Innovative medicinal products
Innovative medicines list: AIFA publishes March 2025 update
07 Apr 2025
Press releases
Interactive OsMed: available online the update on consumption and pharmaceutical expenditure in Italy
04 Apr 2025
Monitoring pharmaceutical expenditure
Monitoring of Pharmaceutical expenditure (January / November 2024)
FarmaciLine
Questions regarding drug efficacy, safety and availability
TOLL-FREE NUMBER
Services
Interactive OsMed - The use of medicines in Italy
An interactive consultation of data on the use of medicines in Italy in the general and regional population, described in terms of expenditure, volumes, typology
